IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $718,000 | -68.4% | 55,000 | -68.8% | 0.01% | -73.3% |
| Q2 2021 | $2,272,000 | -8.4% | 176,548 | -20.4% | 0.03% | -43.4% |
| Q1 2021 | $2,480,000 | +335.1% | 221,700 | +342.4% | 0.05% | +307.7% |
| Q4 2020 | $570,000 | -34.9% | 50,113 | -48.6% | 0.01% | -35.0% |
| Q3 2020 | $876,000 | -53.4% | 97,500 | -46.5% | 0.02% | -68.3% |
| Q2 2020 | $1,880,000 | +314.1% | 182,300 | +305.1% | 0.06% | +142.3% |
| Q1 2020 | $454,000 | -78.5% | 45,000 | -71.7% | 0.03% | -63.4% |
| Q4 2019 | $2,116,000 | +134.9% | 159,000 | +51.4% | 0.07% | +51.1% |
| Q3 2019 | $901,000 | -45.3% | 105,000 | -30.2% | 0.05% | -43.4% |
| Q2 2019 | $1,646,000 | -28.2% | 150,400 | -25.7% | 0.08% | -34.1% |
| Q1 2019 | $2,291,000 | +10.6% | 202,400 | +1.2% | 0.13% | -23.6% |
| Q4 2018 | $2,072,000 | – | 200,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $188,977,000 | 19.02% |
| 13D Management LLC | 600,431 | $6,923,000 | 3.06% |
| BRIDGER MANAGEMENT, LLC | 956,014 | $11,023,000 | 2.48% |
| Brown Capital Management | 11,641,935 | $134,232,000 | 1.80% |
| Price Jennifer C. | 520,000 | $5,996,000 | 1.02% |
| Monarch Partners Asset Management LLC | 272,425 | $3,141,000 | 0.88% |
| ALPHASIMPLEX GROUP, LLC | 10,510 | $121,000 | 0.86% |
| Intrinsic Value Partners, LLC | 54,105 | $624,000 | 0.80% |
| CLARK ESTATES INC/NY | 355,000 | $4,093,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 692 | $60,000,000 | 0.63% |